Joseph Panetta is President and CEO and a member of the Board of Directors of Biocom, the Southern California association that advocates for more than 550 companies, service sector firms, universities and research institutes working in the life sciences. As the head of Biocom since 1999, Panetta has lead programs in capital formation, public policy, workforce education, and member services. He oversees several subsidiaries of Biocom, including a purchasing group that provides more than $35 million in products and services to members. He co-founded the Biocom Political Action Committee and the Biocom Institute for education and workforce development. Joe also is a founder and chairman of the California Biotechnology Foundation, a joint initiative to inform legislators and the media about the life science industry in California.
With the inauguration of Donald Trump as president on January 20th, the editors asked some of our Xconomists to offer their thoughts on “How could the incoming administration significantly affect your... Read more »
The life sciences industry represents a vital piece of San Diego’s innovation economy, contributing $31.8 billion each year in local economic impact—more than defense or even tourism, according to the San... Read more »
I recently led an initiative to communicate more proactively and frequently with the leaders of the FDA about issues specifically related to improving the agency’s focus on innovative biomedical and therapeutic... Read more »
Sponsored · Webinar
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverXSponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
MedpaceFrom Our Editors · Special Report
The AI, Big Data, and R&D Boom
© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.